Your browser doesn't support javascript.
loading
Activation-induced deaminase is critical for the establishment of DNA methylation patterns prior to the germinal center reaction.
Català-Moll, Francesc; Ferreté-Bonastre, Anna G; Li, Tianlu; Weichenhan, Dieter; Lutsik, Pavlo; Ciudad, Laura; Álvarez-Prado, Ángel F; Rodríguez-Ubreva, Javier; Klemann, Christian; Speckmann, Carsten; Vilas-Zornoza, Amaya; Abolhassani, Hassan; Martínez-Gallo, Mónica; Dieli-Crimi, Romina; Rivière, Jacques G; Martín-Nalda, Andrea; Colobran, Roger; Soler-Palacín, Pere; Kracker, Sven; Hammarström, Lennart; Prosper, Felipe; Durandy, Anne; Grimbacher, Bodo; Plass, Christoph; Ballestar, Esteban.
Affiliation
  • Català-Moll F; Epigenetics and Immune Disease Group, Josep Carreras Research Institute (IJC), 08916 Badalona, Barcelona, Spain.
  • Ferreté-Bonastre AG; Chromatin and Disease Group, Cancer Epigenetics and Biology Programme (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), 08908 L'Hospitalet de Llobregat, Barcelona, Spain.
  • Li T; Epigenetics and Immune Disease Group, Josep Carreras Research Institute (IJC), 08916 Badalona, Barcelona, Spain.
  • Weichenhan D; Chromatin and Disease Group, Cancer Epigenetics and Biology Programme (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), 08908 L'Hospitalet de Llobregat, Barcelona, Spain.
  • Lutsik P; Epigenetics and Immune Disease Group, Josep Carreras Research Institute (IJC), 08916 Badalona, Barcelona, Spain.
  • Ciudad L; Chromatin and Disease Group, Cancer Epigenetics and Biology Programme (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), 08908 L'Hospitalet de Llobregat, Barcelona, Spain.
  • Álvarez-Prado ÁF; Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), Heidelberg 69120, Germany.
  • Rodríguez-Ubreva J; Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), Heidelberg 69120, Germany.
  • Klemann C; Epigenetics and Immune Disease Group, Josep Carreras Research Institute (IJC), 08916 Badalona, Barcelona, Spain.
  • Speckmann C; Chromatin and Disease Group, Cancer Epigenetics and Biology Programme (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), 08908 L'Hospitalet de Llobregat, Barcelona, Spain.
  • Vilas-Zornoza A; B Cell Biology Laboratory, Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), 28029 Madrid, Spain.
  • Abolhassani H; Epigenetics and Immune Disease Group, Josep Carreras Research Institute (IJC), 08916 Badalona, Barcelona, Spain.
  • Martínez-Gallo M; Chromatin and Disease Group, Cancer Epigenetics and Biology Programme (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), 08908 L'Hospitalet de Llobregat, Barcelona, Spain.
  • Dieli-Crimi R; Institute for Immunodeficiency, Center for Chronic Immunodeficiency (CCI), Medical Center, Faculty of Medicine, University of Freiburg, 79110 Freiburg, Germany.
  • Rivière JG; Institute for Immunodeficiency, Center for Chronic Immunodeficiency (CCI), Medical Center, Faculty of Medicine, University of Freiburg, 79110 Freiburg, Germany.
  • Martín-Nalda A; Faculty of Medicine, Center for Pediatrics and Adolescent Medicine, Medical Center, University of Freiburg, Germany.
  • Colobran R; Center for Applied Medical Research (CIMA), University of Navarra, 31008 Pamplona, Spain.
  • Soler-Palacín P; Division of Clinical Immunology, Department of Laboratory Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, SE 14186 Stockholm , Sweden.
  • Kracker S; Immunology Division, Hospital Universitari Vall d'Hebron and Diagnostic Immunology Research Group, Vall d'Hebron Research Institute (VHIR), Barcelona, Spain.
  • Hammarström L; Immunology Division, Hospital Universitari Vall d'Hebron and Diagnostic Immunology Research Group, Vall d'Hebron Research Institute (VHIR), Barcelona, Spain.
  • Prosper F; Pediatric Infectious Diseases & Immunodeficiencies Unit, Hospital Universitari Vall d'Hebron, Vall d'Hebron Research Institute (VHIR), Autonomous University of Barcelona, Barcelona, Spain.
  • Durandy A; Infection in Immunocompromised Pediatric Patients Research Group, Vall d'Hebron Institut de Recerca (VHIR), Hospital Universitari Vall d'Hebron, 08035 Barcelona, Spain.
  • Grimbacher B; Jeffrey Modell Diagnostic and Research Center for Primary Immunodeficiencies, Barcelona, Spain.
  • Plass C; Pediatric Infectious Diseases & Immunodeficiencies Unit, Hospital Universitari Vall d'Hebron, Vall d'Hebron Research Institute (VHIR), Autonomous University of Barcelona, Barcelona, Spain.
  • Ballestar E; Infection in Immunocompromised Pediatric Patients Research Group, Vall d'Hebron Institut de Recerca (VHIR), Hospital Universitari Vall d'Hebron, 08035 Barcelona, Spain.
Nucleic Acids Res ; 49(9): 5057-5073, 2021 05 21.
Article in En | MEDLINE | ID: mdl-33950194
ABSTRACT
Activation-induced deaminase (AID) initiates antibody diversification in germinal center B cells by deaminating cytosines, leading to somatic hypermutation and class-switch recombination. Loss-of-function mutations in AID lead to hyper-IgM syndrome type 2 (HIGM2), a rare human primary antibody deficiency. AID-mediated deamination has been proposed as leading to active demethylation of 5-methycytosines in the DNA, although evidence both supports and casts doubt on such a role. In this study, using whole-genome bisulfite sequencing of HIGM2 B cells, we investigated direct AID involvement in active DNA demethylation. HIGM2 naïve and memory B cells both display widespread DNA methylation alterations, of which ∼25% are attributable to active DNA demethylation. For genes that undergo active demethylation that is impaired in HIGM2 individuals, our analysis indicates that AID is not directly involved. We demonstrate that the widespread alterations in the DNA methylation and expression profiles of HIGM2 naïve B cells result from premature overstimulation of the B-cell receptor prior to the germinal center reaction. Our data support a role for AID in B cell central tolerance in preventing the expansion of autoreactive cell clones, affecting the correct establishment of DNA methylation patterns.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: B-Lymphocytes / DNA Methylation / Cytidine Deaminase / Hyper-IgM Immunodeficiency Syndrome Limits: Humans Language: En Journal: Nucleic Acids Res Year: 2021 Document type: Article Affiliation country: España

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: B-Lymphocytes / DNA Methylation / Cytidine Deaminase / Hyper-IgM Immunodeficiency Syndrome Limits: Humans Language: En Journal: Nucleic Acids Res Year: 2021 Document type: Article Affiliation country: España